Dirty surgical tools may have once again placed neurological patients at risk for Creutzfeldt-Jakob disease (CJD), a rare and fatal degenerative condition. It's something that medical device companies are probably watching pretty closely, depending on how the affected medical center managed its operating room.
Italian diagnostics company DiaSorin Group unveiled a new test to detect Rotavirus in stool samples in Europe, hoping to cash in on a €10 million ($13.7 million) a year market, reported Reuters.
A Baxter Healthcare plant in Illinois failed to put in place adequate quality control practices in the manufacture of HomeChoice dialysis and iPump pain management systems, the FDA tells the company in a warning letter.
Demark's Dako and Amgen like working together so much that they're extending their relationship. They've agreed to develop a new molecular diagnostic test in an expansion of an alliance that first began two years ago.
As the FDA keeps pushing for more pediatric-friendly devices, Smith Medical has taking a small but crucial step that helps answer that call.
St. Jude Medical stock spiked 6% in the last week in the wake of progress with its leadless pacemaker, an analyst upgrade and the perception that its rebound story is continuing.
Medical device maker ConvaTec will shutter its Skillman, NJ office and lay off 118 employees from its sales, marketing and human resources division, The Star-Ledger reports.
Already a must-have in med tech research labs, 3-D printing has been sweeping into medical practice. Now it's in a cancer patient's hip.
Two of the biggest players in Brazil's medical diagnostics industry are likely to confront major changes in the coming months-- both worth noting as global competitors seek to enter one of the largest emerging markets around.
We already know that medical device investing continues to plunge, and a new report from The Wall Street Journal places those numbers in stark terms. Some industry insiders told the newspaper, however, that the VC culling has reduce the amount of weak deals and that international trends have planted the seeds for a possible turnaround in 2014.
It's a story that could confirm the worst fears of med tech implant wearers at the highest level of U.S. government: Some time during the first half of 2013, hackers reportedly broke into the computer networks of the big three medical device makers, and the breach might have stayed open for "several months."
Roche's new extended partnership with Cancer Genetics will expand molecular diagnostic cancer testing in the Caribbean and Central America as part of a three-year deal.
Researchers at MIT's Microsystems Technology Laboratory (MTL) and physicians from Harvard Medical School and the Massachusetts Eye and Ear Infirmary (MEEI) developed an innovative, low-power signal-processing chip that could provide an alternative to cochlear implants.
India made some noise last year with news that it wants to modernize its regulation of medical devices and drugs. Now The Economic Times is reporting that the government plans to take its time getting there.
Medtronic has failed to prevent another lawsuit involving its Infuse bone growth spinal implant from advancing. It's an ominous sign as the Minnesota device giant gears up for a growing number of related cases that are working their way through the court system.
The U.S. Department of Defense is pursuing the creation of brain implants that could treat brain injury-related memory loss, an initiative that could benefit companies ranging from Medtronic to General Electric and more.
Weeks ago, Myriad Genetics alarmed investors when news broke that Medicare reimbursement for its signature predictive cancer test would be slashed nearly in half. Now, in the wake of stellar financial results and news of a major acquisition, investors are in the midst of an ongoing "happy dance."
Insulet is moving on to greener pastures: Following a year of growth, the company will relocate its headquarters from Bedford, MA, to a larger space in nearby Billerica, reports the Boston Business Journal.
Insurance reimbursement challenges continued to dog diagnostics giant LabCorp as it closed out 2013. But the Burlington, NC, company booked some growth in net sales and income, a small dose of positive news after months with hundreds of jobs slashed, a restructuring, new product launches and an acquisition.
Sorin Group offered up some unaudited results for the fourth quarter of 2013, Thursday, telling investors its net profit was up 80.3% compared to the final quarter of 2012.